Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI-Reference-Cited by-同舟云学术

Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI

Published:2020-05-25 Issue:11 Volume:45 Page:3896-3906
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Paparo Francesco,Peirano Alice,Matos João^ORCID,Bacigalupo Lorenzo,Rossi Umberto,Mussetto Ilaria,Bottoni Gianluca,Ugolini Martina,Introini Carlo,Ruggieri Filippo Grillo,Rollandi Gian Andrea,Piccardo Arnoldo

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-020-02591-7.pdf

Reference20 articles.

1. Trabulsi EJ, Rumble RB, Jadvar H, et al (2020) Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol JCO1902757. https://doi.org/10.1200/JCO.19.02757

2. Maurer T, Eiber M, Fanti S, et al (2016) Imaging for Prostate Cancer Recurrence. Eur Urol Focus 2:139–150. https://doi.org/10.1016/j.euf.2016.02.006

3. Perez-Lopez R, Tunariu N, Padhani AR, et al (2019) Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art. Radiology 292:273–286. https://doi.org/10.1148/radiol.2019181931https://doi.org/10.1148/radiol.2019181931

4. Gaur S, Turkbey B (2018) Prostate MR Imaging for Posttreatment Evaluation and Recurrence. Radiol Clin North Am 56:263–275. https://doi.org/10.1016/j.rcl.2017.10.008

5. Piccardo A, Paparo F, Piccazzo R, et al (2014) Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results. Biomed Res Int 2014:103718. https://doi.org/10.1155/2014/103718

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Preclinical Studies of the Theranostic Agent [64Cu]CuCl2;Molecules;2024-08-28

2. Role of⁶⁴CuCl₂PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and¹⁸F-FDG PET/CT;Journal of Nuclear Medicine;2024-07-25

3. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review;Journal of Cancer Research and Clinical Oncology;2024-04-25

4. Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent;Journal of Clinical Medicine;2022-12-28

5. Recent Advances in Cancer Imaging with 64CuCl2 PET/CT;Nuclear Medicine and Molecular Imaging;2022-02-17